Imagine how it goes.  You're sick enough from COVID that you're in the hospital.  There's a possibility that you could die.  You get asked if you want to participate in a study of a new drug.  What's your decision, especially if no other COVID patient has yet received the drug?  If a number of people are treated and it works well, recruitment will no doubt speed up.